相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Hepatic Intra-arterial Delivery of a Trojan-horses Gene Therapy: A Pilot Study on Rabbit VX2 Hepatic Tumor Model
Olivier Pellerin et al.
CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2018)
Cell death and immunity in cancer: From danger signals to mimicry of pathogen defense responses
Abhishek D. Garg et al.
IMMUNOLOGICAL REVIEWS (2017)
Low dose cyclophosphamide: Mechanisms of T cell modulation
Mutsa Tatenda Madondo et al.
CANCER TREATMENT REVIEWS (2016)
Engineered mesenchymal stem cells as vectors in a suicide gene therapy against preclinical murine models for solid tumors
Ikrame Amara et al.
JOURNAL OF CONTROLLED RELEASE (2016)
Treatment with Anti-HMGB1 Monoclonal Antibody Does Not Affect Lupus Nephritis in MRL/lpr Mice
Fleur Schaper et al.
MOLECULAR MEDICINE (2016)
Immunological Effects of Conventional Chemotherapy and Targeted Anticancer Agents
Lorenzo Galluzzi et al.
CANCER CELL (2015)
Molecular and Translational Classifications of DAMPs in Immunogenic Cell Death
Abhishek D. Garg et al.
FRONTIERS IN IMMUNOLOGY (2015)
Combinatorial strategies for the induction of immunogenic cell death
Lucillia Bezu et al.
FRONTIERS IN IMMUNOLOGY (2015)
Mesenchymal stem cells as cellular vehicles for prodrug gene therapy against tumors
Ikrame Amara et al.
BIOCHIMIE (2014)
Multimodal immunogenic cancer cell death as a consequence of anticancer cytotoxic treatments
H. Inoue et al.
CELL DEATH AND DIFFERENTIATION (2014)
Molecular mechanisms of ATP secretion during immunogenic cell death
I. Martins et al.
CELL DEATH AND DIFFERENTIATION (2014)
A Suicide Gene Therapy Combining the Improvement of Cyclophosphamide Tumor Cytotoxicity and the Development of an Anti-Tumor Immune Response
Walid Touati et al.
CURRENT GENE THERAPY (2014)
Apoptotic cell clearance: basic biology and therapeutic potential
Ivan K. H. Poon et al.
NATURE REVIEWS IMMUNOLOGY (2014)
T cell responses: naive to memory and everything in between
Nathan D. Pennock et al.
ADVANCES IN PHYSIOLOGY EDUCATION (2013)
Immunogenic Cell Death in Cancer Therapy
Guido Kroemer et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 31 (2013)
Chemotherapy-induced immunogenic modulation of tumor cells enhances killing by cytotoxic T lymphocytes and is distinct from immunogenic cell death
James W. Hodge et al.
INTERNATIONAL JOURNAL OF CANCER (2013)
Strange attractors: DAMPs and autophagy link tumor cell death and immunity
W. Hou et al.
CELL DEATH & DISEASE (2013)
Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome
Yingzi Ge et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Regulatory T-cell Modulation Using Cyclophosphamide in Vaccine Approaches: A Current Perspective
Dung T. Le et al.
CANCER RESEARCH (2012)
A novel pathway combining calreticulin exposure and ATP secretion in immunogenic cancer cell death
Abhishek D. Garg et al.
EMBO JOURNAL (2012)
The secret ally: immunostimulation by anticancer drugs
Lorenzo Galluzzi et al.
NATURE REVIEWS DRUG DISCOVERY (2012)
Immunogenic cell death and DAMPs in cancer therapy
Dmitri V. Krysko et al.
NATURE REVIEWS CANCER (2012)
Cyclophosphamide Synergizes with Type I Interferons through Systemic Dendritic Cell Reactivation and Induction of Immunogenic Tumor Apoptosis
Giovanna Schiavoni et al.
CANCER RESEARCH (2011)
Immunogenic death of colon cancer cells treated with oxaliplatin
A. Tesniere et al.
ONCOGENE (2010)
A critical cysteine is required for HMGB1 binding to Toll-like receptor 4 and activation of macrophage cytokine release
Huan Yang et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Chemotherapy induces ATP release from tumor cells
Isabelle Martins et al.
CELL CYCLE (2009)
Autophagy regulates selective HMGB1 release in tumor cells that are destined to die
J. Thorburn et al.
CELL DEATH AND DIFFERENTIATION (2009)
Mechanisms of pre-apoptotic calreticulin exposure in immunogenic cell death
Theocharis Panaretakis et al.
EMBO JOURNAL (2009)
Activation of the NLRP3 inflammasome in dendritic cells induces IL-1β-dependent adaptive immunity against tumors
Francois Ghiringhelli et al.
NATURE MEDICINE (2009)
Cyclophosphamide and cancer: golden anniversary
Ashkan Emadi et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2009)
Improvement of cyclophosphamide activation by CYP2B6 mutants: From in silico to ex vivo
Thien-An Nguyen et al.
MOLECULAR PHARMACOLOGY (2008)
Ecto-calreticulin in immunogenic chemotherapy
Michel Obeid et al.
IMMUNOLOGICAL REVIEWS (2007)
Exocytotic release of ATP from cultured Astrocytes
Tina Pangrsic et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Toll-like receptor 4-dependent contribution of the immune system to anticancer chemotherapy and radiotherapy
Lionel Apetoh et al.
NATURE MEDICINE (2007)
Metronomic cyclophosphamide regimen selectively depletes CD4+ CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients
Francois Ghiringhelli et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2007)
Cyclophosphamide enhances the antitumor efficacy of adoptively transferred immune cells through the induction of cytokine expression, B-cell and T-cell homeostatic proliferation, and specific tumor infiltration
Laura Bracci et al.
CLINICAL CANCER RESEARCH (2007)
Calreticulin exposure dictates the immunogenicity of cancer cell death
Michel Obeid et al.
NATURE MEDICINE (2007)
Intra-tumoural regulatory T cells: A potential new target in cancer immunotherapy
DJ Needham et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2006)
Tumor cells convert immature myeloid dendritic cells into TGF-β-secreting cells inducing CD4+CD25+ regulatory T cell proliferation
F Ghiringhelli et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2005)
A virus-directed enzyme prodrug therapy (VDEPT) strategy for lung cancer using a CYP2B6/NADPH-cytochrome P450 reductase fusion protein
M Tychopoulos et al.
CANCER GENE THERAPY (2005)
Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells:: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance
S Sakaguchi et al.
IMMUNOLOGICAL REVIEWS (2001)
分享论文
